Thermo Fisher Scientific Inc.’s TMO recent slew of product launches reflects its ongoing commitment to innovation. The company gains early insights into customer needs through its strong partnerships, ...

Thermo Fisher Scientific (NYSE:TMO – Get Free Report) will likely be issuing its quarterly earnings data before the market ...

Investors focused on top-and-bottom-line performance—important as they are—do so at the risk of neglecting another crucial ...

Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

The CDMO's growth strategy, capital deployment approach, and work with AI, among other things, have been key to its 2024 ...

Thermo Fisher Scientific Inc (TMO) stock saw a modest uptick, ending the day at $573.06 which represents a slight increase of $13.41 or 2.40% from the prior close of $559.65. The stock opened at $563 ...

Shares of Thermo Fisher Scientific Inc. TMO rose 1.86% to $561.71 Thursday, on what proved to be an all-around rough trading ...

Wedge Capital Management L L P NC grew its holdings in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) by ...

In a report released on January 10, Conor McNamara from RBC Capital maintained a Buy rating on Thermo Fisher (TMO – Research Report), with a ...

Morgan Stanley analyst Tejas Savant maintained a Buy rating on Thermo Fisher (TMO – Research Report) today and set a price target of $647.00.

After revenue boomed for biopharma manufacturers during the COVID pandemic, sales have stagnated for several CDMO giants, ...